Ligand-targeted bacterial minicells: Futuristic nano-sized drug delivery system for the efficient and cost effective delivery of shRNA to cancer cells
- 1 November 2016
- journal article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 12 (8) , 2485-2498
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Recent progress in copolymer-mediated siRNA deliveryJournal of Drug Targeting, 2012
- Efficient and targeted delivery of siRNA in vivoThe FEBS Journal, 2010
- siRNA delivery systems for cancer treatmentAdvanced Drug Delivery Reviews, 2009
- Chitosan–plasmid nanoparticle formulations for IM and SC delivery of recombinant FGF-2 and PDGF-BB or generation of antibodiesGene Therapy, 2009
- Lentivirus‐Mediated Small Interfering RNA Targeting VEGF‐C Inhibited Tumor Lymphangiogenesis and Growth in Breast CarcinomaThe Anatomical Record, 2009
- Liposomal nanomedicinesExpert Opinion on Drug Delivery, 2007
- Hydrophobization and bioconjugation for enhanced siRNA delivery and targetingRNA, 2007
- Targeted Delivery Systems of Small Interfering RNA by Systemic AdministrationDrug Metabolism and Pharmacokinetics, 2007
- Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cellsNature, 2001
- Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegansNature, 1998